Where Does Dynamic Value Assessment Fit Into Our Role as Agents Advising Our Patients With Cancer?

Blayney, Douglas W.

doi:10.1200/jop.2016.016022

Cited by 2 publications

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Some authorities have posited that physicians will rise to the challenge of discussing value with their patients. 30 However, panelists in our study were only somewhat enthusiastic about the process of conducting individual drug assessments, and the hour spent reviewing literature and conducting just 1 assessment may be more time than most oncologists are able to devote. ASCO promises to develop a user-modifiable software tool with populated drug data and user-modifiable category weights, ICER intends to publish more reports, and ESMO proposes to assess every newly approved anticancer drug.…”

Section: ■■ Discussionmentioning

confidence: 87%

Measuring the Value of New Drugs: Validity and Reliability of 4 Value Assessment Frameworks in the Oncology Setting

Bentley

Cohen

Elkin

et al. 2017

JMCP

View full text Add to dashboard Cite

This work was funded by Eisai Inc. Copher and Knoth are employees of Eisai Inc. Bentley, Lee, Zambrano, and Broder are employees of Partnership for Health Analytic Research, a health services research company paid by Eisai Inc. to conduct this research. For this study, Cohen, Huynh, and Neville report fees from Partnership for Health Analytic Research. Outside of this study, Cohen receives grants and direct consulting fees from various companies that manufacture and market pharmaceuticals. Mei reports a grant from Eisai Inc. during this study. The other authors have no disclosures to report. Study concept and design were contributed by Bentley and Broder, with assistance from Elkin and Cohen. Bentley took the lead in data collection, along with Elkin, Huynh, Mukherjea, Neville, Mei, Popescu, Lee, and Zambrano. Data interpretation was performed by Bentley and Broder, along with Elkin, Cohen, Copher, and Knoth. The manuscript was written primarily by Bentley, along with Elkin and Broder, and revised by Bentley, Broder, Elkin, Cohen, Copher, and Knoth. Select components of this work's methods were presented at ISPOR 19th Annual European Congress held in Vienna, Austria, October 29-November 2, 2016, and Society for Medical Decision Making 38th Annual North American Meeting held in Vancouver, Canada, October 23-26, 2016.

show abstract

Section: ■■ Discussionmentioning

confidence: 87%